ATC
MDT icon

Advantage Trust Company’s Medtronic MDT Stock Holding History

Advantage Trust Company’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-18
Closed -$1.44K – 175
2024
Q4 		$1.44K Buy
+18
New +$1.56K ﹤0.01% 183
2024
Q1 		– Sell
-600
Closed -$49.4K – 175
2023
Q4 		$49.4K Buy
+600
New +$45.7K 0.04% 116

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Advantage Trust Company's MDT Position: Q1 2025 in Review

Advantage Trust Company sold out of Medtronic (MDT) in Q1 2025, closing a stake of 18 shares — an estimated $1.44K sold.

Advantage Trust Company first reported a position in MDT in Q4 2023 and held it in 2 quarters. The position peaked at $49.4K in Q4 2023. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.

  • Advantage Trust Company reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
  • Advantage Trust Company sold 18 Medtronic shares in Q1 2025, an estimated $1.44K.
  • Advantage Trust Company first reported a position in Medtronic in Q4 2023 and held it in 2 quarters.
  • Advantage Trust Company's Medtronic position peaked at $49.4K in Q4 2023.
  • 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.

Based on Advantage Trust Company's 13F filing for Q1 2025, filed 7 May 2025.